BioCentury | Jul 20, 2018
Company News

Cas3 antimicrobial company acquires Epibiome tech

...Biosciences Inc. (Research Triangle Park, N.C.) acquired a phage discovery platform from fellow antibacterial company EpiBiome Inc....
...specific pathogenic species while sparing human cells and the microbiome (see "Cutting Through Resistance" ). EpiBiome’s...
...EpiBiome Inc., South San Francisco, Calif. Locus Biosciences Inc., Research Triangle Park, N.C. Business: Infectious Elizabeth S. Eaton EpiBiome Inc. Locus...
BioCentury | Jul 17, 2018
Company News

Cas3 antimicrobial company acquires EpiBiome tech

...Biosciences Inc. (Research Triangle Park, N.C.) acquired a phage discovery platform from fellow antibacterial company EpiBiome Inc....
...specific pathogenic species while sparing human cells and the microbiome (see "Cutting Through Resistance" ). EpiBiome’s...
...and precisely edit the microbiome," Locus CEO Paul Garofolo told BioCentury. The company will incorporate EpiBiome’s...
BioCentury | Feb 23, 2017
Tools & Techniques

Showdown: bacteria vs. virus

...into the space. The company raised an undisclosed series A round last year, joining newco EpiBiome Inc....
...the exclusive species- or strain-level selectivity and mechanistic specificity that lytic phages provide." Nick Conley, EpiBiome...
...represent one of the few technologies with potential to durably modify the gut microbiome," said EpiBiome...
BioCentury | Jun 27, 2016
Financial News

EpiBiome financial update

...EpiBiome Inc. , South San Francisco, Calif. Business: Infectious Date announced: 2016-06-23 Note: EpiBiome secured a...
BioCentury | Apr 16, 2015
Finance

Public-Private Partnership Roundup

...pharma recently made with biotechs in the microbiome space. In March, J&J included microbiome company EpiBiome Inc....
...Institute for Quantitative Biosciences (QB3), San Francisco, Calif. Columbia University Medical Center, New York, N.Y. EpiBiome Inc....
BioCentury | Mar 9, 2015
Company News

J&J other, pharmaceuticals news

...with aging. The others are MiNDERA Corp., a diagnostics company focused on skin diseases; and EpiBiome Inc....
BioCentury | Mar 4, 2015
Company News

J&J launches second Bay Area JLABS incubator

...with aging. The others are MiNDERA Corp., a diagnostics company focused on skin diseases; and EpiBiome Inc....
BioCentury | Mar 2, 2015
Financial News

Illumina Inc financial update

...companies in October 2014: therapeutics company Encoded Genomics Inc. (San Francisco, Calif.), veterinary technology developer EpiBiome Inc....
BioCentury | Feb 27, 2015
Financial News

Illumina raises $40M for accelerator matching fund

...companies in October 2014: therapeutics company Encoded Genomics Inc. (San Francisco, Calif.), veterinary technology developer EpiBiome Inc....
BioCentury | Oct 27, 2014
Financial News

EpiBiome completes venture financing

EpiBiome Inc. , San Francisco, Calif. Business: Veterinary Date completed: 2014-10-15 Type: Venture financing Raised: $100,000 Investor: Illumina Inc. Note: The offering comprises convertible notes. The company also has an unsecured equity line of $20,000 from...
Items per page:
1 - 10 of 10
BioCentury | Jul 20, 2018
Company News

Cas3 antimicrobial company acquires Epibiome tech

...Biosciences Inc. (Research Triangle Park, N.C.) acquired a phage discovery platform from fellow antibacterial company EpiBiome Inc....
...specific pathogenic species while sparing human cells and the microbiome (see "Cutting Through Resistance" ). EpiBiome’s...
...EpiBiome Inc., South San Francisco, Calif. Locus Biosciences Inc., Research Triangle Park, N.C. Business: Infectious Elizabeth S. Eaton EpiBiome Inc. Locus...
BioCentury | Jul 17, 2018
Company News

Cas3 antimicrobial company acquires EpiBiome tech

...Biosciences Inc. (Research Triangle Park, N.C.) acquired a phage discovery platform from fellow antibacterial company EpiBiome Inc....
...specific pathogenic species while sparing human cells and the microbiome (see "Cutting Through Resistance" ). EpiBiome’s...
...and precisely edit the microbiome," Locus CEO Paul Garofolo told BioCentury. The company will incorporate EpiBiome’s...
BioCentury | Feb 23, 2017
Tools & Techniques

Showdown: bacteria vs. virus

...into the space. The company raised an undisclosed series A round last year, joining newco EpiBiome Inc....
...the exclusive species- or strain-level selectivity and mechanistic specificity that lytic phages provide." Nick Conley, EpiBiome...
...represent one of the few technologies with potential to durably modify the gut microbiome," said EpiBiome...
BioCentury | Jun 27, 2016
Financial News

EpiBiome financial update

...EpiBiome Inc. , South San Francisco, Calif. Business: Infectious Date announced: 2016-06-23 Note: EpiBiome secured a...
BioCentury | Apr 16, 2015
Finance

Public-Private Partnership Roundup

...pharma recently made with biotechs in the microbiome space. In March, J&J included microbiome company EpiBiome Inc....
...Institute for Quantitative Biosciences (QB3), San Francisco, Calif. Columbia University Medical Center, New York, N.Y. EpiBiome Inc....
BioCentury | Mar 9, 2015
Company News

J&J other, pharmaceuticals news

...with aging. The others are MiNDERA Corp., a diagnostics company focused on skin diseases; and EpiBiome Inc....
BioCentury | Mar 4, 2015
Company News

J&J launches second Bay Area JLABS incubator

...with aging. The others are MiNDERA Corp., a diagnostics company focused on skin diseases; and EpiBiome Inc....
BioCentury | Mar 2, 2015
Financial News

Illumina Inc financial update

...companies in October 2014: therapeutics company Encoded Genomics Inc. (San Francisco, Calif.), veterinary technology developer EpiBiome Inc....
BioCentury | Feb 27, 2015
Financial News

Illumina raises $40M for accelerator matching fund

...companies in October 2014: therapeutics company Encoded Genomics Inc. (San Francisco, Calif.), veterinary technology developer EpiBiome Inc....
BioCentury | Oct 27, 2014
Financial News

EpiBiome completes venture financing

EpiBiome Inc. , San Francisco, Calif. Business: Veterinary Date completed: 2014-10-15 Type: Venture financing Raised: $100,000 Investor: Illumina Inc. Note: The offering comprises convertible notes. The company also has an unsecured equity line of $20,000 from...
Items per page:
1 - 10 of 10